PANCREAS CANCER
Clinical trials for PANCREAS CANCER explained in plain language.
Never miss a new study
Get alerted when new PANCREAS CANCER trials appear
Sign up with your email to follow new studies for PANCREAS CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Pancreatic cancer drug combo study halted after just 4 patients
Disease control TerminatedThis early-phase study aimed to see if adding the experimental drug NIS793 to standard chemotherapy (FOLFIRINOX) was safe and effective for people with pancreatic cancer that had spread. Only 4 people took part before the study was stopped early. The goal was to find the right do…
Matched conditions: PANCREAS CANCER
Phase: PHASE1 • Sponsor: Colin D. Weekes, M.D., PhD • Aim: Disease control
Last updated Jun 16, 2026 12:52 UTC
-
Experimental cancer drug study halted early
Disease control TerminatedThis study tested a new drug called NUV-868, alone or with other drugs (olaparib or enzalutamide), in 82 adults with advanced solid tumors like ovarian, pancreatic, prostate, or breast cancer. The goal was to find safe doses and see if the combination worked better. The study was…
Matched conditions: PANCREAS CANCER
Phase: PHASE1 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated Jun 09, 2026 12:07 UTC